Organoid technology has emerged as one of the most groundbreaking and cutting-edge technologies in the biomedical field. It finds widespread applications in disease modeling, drug discovery and screening, companion diagnostics, cell therapy, regenerative medicine, and more.
Senior Manager of Science & Development has started
AppointmentsSwedish biotech startup AAX Biotech strengthens the management team with the appointment of Juan Astorga-Wells. He became new Senior Manager of Science & Development.
Pierre Fabre SAS in US$31m licence deal with Kinnate Biopharma Inc
Latest NewsPierre Fabre Médicament SAS has entered into an Asset Purchase Agreement (APA) over pan-RAF programs developed by Kinnate Biopharma Inc.
PulseSight to disrupt AMD space
Latest NewsPulseSight Therapeutics SAS was launched on Wednesday, backed by seed financing from Pureos Bioventures and ND Capital. The company introduces a disruptive delivery platform in ophthalmology biotech, focusing on the development of non-viral gene therapies coupled with minimally-invasive delivery technology.
Swiss vaccine developer Limma Tech get CARB-X grant
Latest NewsSwiss multivalent vaccine developer LimmaTech Biologics AG has been awarded US$2.2m rom the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).
Curve Therapeutics raises £40.5m in Series A financing
Latest NewsIntracellular cancer target screening specialist Curve Therapeutics Ltd has closed a £40.5m financing led by Pfizer Ventures to advance its preclinical pipeline of small cyclic petides.
Pacifico Biolabs raises US$3.3m in pre-seed round
Latest NewsGerman foodtech start-up Pacifico Biolabs has raised US$3.3m to push the development of healthy animal-free, carbon-neutrally produced fish and seafood.
Organoid Research
ProductsOrganoid technology has emerged as one of the most groundbreaking and cutting-edge technologies in the biomedical field. It finds widespread applications in disease modeling, drug discovery and screening, companion diagnostics, cell therapy, regenerative medicine, and more.
Gene therapy supplier MIP Discovery closes £7M Series A financing
Latest NewsMIP Discovery Ltd has closed a £7M Series A financing to drive commercialisation of its synthetic affinity reagents in cell and gene therapy.
Vidac Pharma Holding plc reports preclinical proof of principle
Latest NewsLondon-based Vidac Pharma Holding plc reported that its Warburg effect blocker VDA-1275 increased efficacy of chemotherapeutics 1000-fold in human organoid cancer models for liver cancer.
GMP PharmaCongress 2024 – Vaccines, ATMP and more
Sponsored PublicationsIn addition to classic aseptic manufacturing topics, the international GMP PharmaCongress and GMP Pharmatechnica Expo 2024 in Wiesbaden will also address global challenges with modern vaccines and novel drugs based on cell and gene therapies. The event thus offers a comprehensive programme for experts from pharmaceutical manufacturing, technology and quality assurance from industry, labs and authorities, as well as a platform for the direct exchange of knowledge and experience.